Efficacy and Safety of Fexinidazole in Children at Least 6 Years Old and Weighing Over 20 kg With Human African Trypanosomiasis (HAT) Due to T.b. Gambiense: a Prospective, Multicentre, Open Study, plug-in to the Pivotal Study
PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment
125
Participants
Timeline
Start Date
May 3, 2014
Primary Completion Date
December 14, 2016
Study Completion Date
June 27, 2017
Conditions
Human African Trypanosomiasis (HAT)
Interventions
DRUG
fexinidazole
Trial Locations (1)
Unknown
Kinshasa
All Listed Sponsors
lead
Drugs for Neglected Diseases
OTHER
NCT02184689 - Efficacy and Safety of Fexinidazole in Children at Least 6 Years Old and Weighing Over 20 kg With Human African Trypanosomiasis (HAT) Due to T.b. Gambiense: a Prospective, Multicentre, Open Study, plug-in to the Pivotal Study | Biotech Hunter | Biotech Hunter